openPR Logo
Press release

Cancer Diagnostics Market Contributing 11.7% Growth Rate and Presaging Players Like Thermo Fisher, Illumina, Siemens, Hologic, Inc and More

07-03-2018 01:50 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Cancer Diagnostics

Cancer Diagnostics

The Cancer Diagnostics Market report contains data for historic years 2015, the base year of calculation is 2016 and the Cancer Diagnostics Market forecast period is 2017 to 2024.

Global Cancer Diagnostics Market is expected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.

The global cancer diagnostics market is segmented on the basis of Technology, Application And Geography.

Get Free Sample PDF of This Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-diagnostics-market

The global cancer diagnostics market is segmented into 2 types, namely platform based and instrument based. In 2017, the cancer diagnostics instrument based segment is expected to dominate the market with a share of 68.8% and is expected to continue this trend till 2024.

Cancer diagnostics platform based market is segmented into Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next Generation Sequencing (NGS), DNA microarrays, flow cytometry and others. Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography- Computed Tomography (PET-CT), mammography and ultrasound.

On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

North America Industry Segmentation

North America cancer diagnostics is expected to reach USD 17.72 billion by 2024 from USD 7.59 billion in 2016, at a CAGR of 11.2% in the forecast period 2017 to 2024.

The major factors driving the growth of this market are the technological advancement in the field of early detection of cancer and high investment in cancer research by North America. These factors increase the demand for cancer diagnostic products.

Technology: Cancer diagnostics instrument based segment is expected to dominate the market with a share of 69.4% and is expected to continue this trend till 2024.

Application: On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Top Players: GE Healthcare is going to dominate the cancer diagnostics market, by imaging following with Siemens Healthcare GmbH along with others such as Hologic, Inc, Becton, Dickinson & Company. Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as Roche Diagnostics, Abbott Laboratories, Inc. QIAGEN

Speak to Research Analyst for Regional Customization or Other Query: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cancer-diagnostics-market

Europe Industry Segmentation

Europe cancer diagnostics is expected to reach USD 13.02 billion by 2024 from USD 5.16 billion in 2016, at a CAGR of 12.3% in the forecast period 2017 to 2024. The major factors driving the growth of this market are the rise in the aging population in European countries and government initiatives. These factors increase the demand for cancer diagnostic products.

Technology: The cancer diagnostics instrument based segment is expected to dominate the market with a share of 67.5% and is expected to continue this trend till 2024.

Application: The market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Top Players: Siemens Healthcare is going to dominate the cancer diagnostics market, by imaging following with Hologic, Inc, Becton, Dickinson and Company. Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as Roche Diagnostics, Abbott Laboratories, Inc., QIAGEN

Asia-Pacific Industry Segmentation

APAC cancer diagnostics is expected to reach USD 7.10 billion by 2024 from USD 2.70 billion in 2016, at a CAGR of 12.7% in the forecast period 2017 to 2024. The major factors driving the growth of this market are the increasing medical tourism in Asia Pacific regions and technological development and increasing market reach by Asian countries. These factors increase the demand for cancer diagnostic products.

Technology: cancer diagnostics instrument based segment is expected to dominate the market with a share of 70.2% and is expected to continue this trend till 2024.

Application: The market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

Top Players: F. Hoffman-La Roche Ltd is going to dominate the cancer diagnostics market, by platform based following with Abbott Laboratories Inc along with QIAGEN.

Table Of Content

Introduction
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Global Cancer Diagnostics Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered

Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions

Market Overview
3.1. Drivers

3.1.1. Growth Of Aging Population And Rising Prevalence Of Cancer
3.1.2. Government Initiatives For Funding And Awareness About Cancer
3.1.3. Key Players Focusing On Strategic Decisions To Gain Market Share
3.1.4. Increasing Prevelance Of Cancer

3.2. Restraints

3.2.1. Stringent Reulations Imposed By International And Local Authorities
3.2.2. Shortage Of Skilled And Trained Professionals

3.3. Opportunities

Continue…

Want Full Report? Enquire Here: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-diagnostics-market

About Us

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing sopan.gedam@databridgemarketresearch.com . We are content with our glorious 99.9 % client satisfying rate.

Contact Us

Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sopan.gedam@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cancer Diagnostics Market Contributing 11.7% Growth Rate and Presaging Players Like Thermo Fisher, Illumina, Siemens, Hologic, Inc and More here

News-ID: 1107990 • Views:

More Releases from Data Bridge Market Research

Water Treatment System Market: Sustaining the Future of Clean Water
Water Treatment System Market: Sustaining the Future of Clean Water
Introduction Understanding Water Treatment Systems Water treatment systems are designed to purify and disinfect water for various uses-drinking, industrial processes, irrigation, and wastewater reuse. These systems eliminate contaminants such as bacteria, viruses, heavy metals, chemicals, and particulates, making water safe and sustainable for consumption and use. Importance in Global Sustainability Clean water is essential to life and industrial progress. With growing water demand and pollution, water treatment systems are now critical infrastructure across the
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
Veterinary X-Ray Market Size, Analysis, Scope, Demand, Opportunities, Statistics
According to Data Bridge Market Research The global Veterinary X-Ray market size was valued at USD 915.19 million in 2024 and is projected to reach USD 1576.00 million by 2032, with a CAGR of 7.03 % during the forecast period of 2025 to 2032. With increasing globalization and digital disruption, the Equine X-Ray Solutions Market is expanding across multiple industries, . Market research data indicates that businesses in the Companion Animal

All 5 Releases


More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports. Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For